Century Health, an AI-enabled real-world evidence platform, has formed a strategic partnership with neurology practice Nira Medical to transform electronic health record (EHR) data from multiple sclerosis (MS) patients into actionable insights. The collaboration will focus on curating and analyzing data from more than 3,000 MS patients across Nira Medical's clinical network, using Century Health's HIPAA-compliant and SOC 2-certified AI platform.
The partnership aims to create structured datasets from both retrospective and prospective EHR data, enabling Nira Medical to develop comprehensive insights into critical aspects of MS treatment. These aspects include disease subtypes, treatment histories, disease progression patterns, and relapse rates. The initiative will facilitate collaboration with life sciences companies to accelerate research and improve access to new treatments.
Vish Srivastava, cofounder and CEO of Century Health, outlined the partnership's vision: "Our vision is to revolutionize how clinical data powers innovation in healthcare. We've only begun to scratch the surface of the vast, siloed data that can unlock life-changing research and therapies. By partnering with forward-thinking providers and harnessing advanced AI to process data at scale, Century Health is creating win-wins that ultimately benefit millions of patients."
Dr. John Foley, medical director of clinical affairs at Nira Medical, emphasized the unique challenges in neurology data collection: "Neurology is a complex field, and neurologists' documentation of patient encounters is often filled with rich descriptive information that doesn't lend itself to the structured checkboxes and lists found in most electronic health record templates. Artificial intelligence and machine learning are the tools needed to extract meaningful data from the neurology record, data that accurately represent the patient's history, treatment plan and response to therapeutic intervention. When these tools are applied precisely, we will be able to truly follow the neurology patient journey and aggregate data in the most insightful manner to better improve patient care."
The selection of MS as the initial focus area is strategic, leveraging Nira Medical's substantial patient population and the diverse array of available therapies for analysis. This initiative comes at a crucial time, as recent National Institutes of Health data indicates that MS affects approximately 2.8 million people worldwide, with increasing prevalence since 2013. The disease, which predominantly affects females at twice the rate of males, typically manifests around age 32, with a global incidence rate of 2.1 per 100,000 persons annually.
Click here for the original news story.